O13 Innate immunity transcriptional profiles as potential predictive biomarkers for treatment response in systemic lupus erythematosus: Insights from a longitudinal study
Main Authors: | Dimitrios T Boumpas, Antonis Fanouriakis, George Bertsias, Dionysis Nikolopoulos, Anastasia Filia, Myrto Nikoloudaki, Panagiotis Garantziotis, Ricardo Grieshaber-Bouyer, George Sentis, Dimitra Nikoleri, Georgia-Savina Moysidou, Stavros Doumas, Styliani Polia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
by: Panagiotis Garantziotis, et al.
Published: (2022-05-01) -
Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
by: Dimitrios Nikolakis, et al.
Published: (2023-04-01) -
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study
by: Myrto Nikoloudaki, et al.
Published: (2023-01-01) -
Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort
by: Dionysis Nikolopoulos, et al.
Published: (2022-05-01) -
P88 Baseline factors associated with subsequent development of incident nephritis in patients with systemic lupus erythematosus: a retrospective cohort study
by: Dimitrios T Boumpas, et al.
Published: (2024-03-01)